Table 1 Demographic and clinical characteristics of PA patients and healthy controls.

From: Noninvasive evaluation of renal oxygenation by blood oxygenation level-dependent magnetic resonance imaging in patients with primary aldosteronism

 

PA

HCs

p

Sex (male: female)

19:29

11:16

 

Age, years

50.10 ± 11.63

46.22 ± 6.72

0.107

BMI, kg/m2

25.21 ± 3.48

22.36 ± 2.63

0.001

SBP, mmHg

151 ± 19

111 ± 4

< 0.001

DBP, mmHg

98 ± 12

76 ± 5

< 0.001

PAC, ng/dL

27.30 (18.40–49.30)

  

DRC, µIU/mL

2.76 (1.01–5.78)

  

ARR, ng/dL:µIU/mL

8.00 (3.90-27.47)

  

Potassium, mmoL/L

3.24 ± 0.58

  

BUN, mmoL/L

4.47 ± 1.21

  

Creatinine, µmoL/L

68.76 ± 14.69

  

Uric acid, µmoL/L

331.48 ± 80.55

  

Serum cystatin C, mg/L

0.97 ± 0.16

  

eGFR, mL/min/1.73m2

97.21 ± 15.41

  
  1. Notes: Data are presented as the mean ± standard deviation and median (interquartile range), and sex is presented as the number of individuals. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PAC, plasma aldosterone concentration; DRC, direct renin concentration; ARR, plasma aldosterone-to-renin ratio; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; PA, primary aldosteronism; HCs, healthy controls.